Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.

Takashi KasaiKiyoshi MoriTomohide SugiyamaNobuyuki KoyamaYoichi NakamuraFumiyoshi OhyanagiHiroki FukudaEishin HoshiKunihiko KobayashiMitsuo Nakayama

Published in: International journal of clinical oncology (2022)

on days 1 and 8 every 3 weeks. The combination of nedaplatin and nab-paclitaxel appears safe and efficacious in patients with untreated advanced squamous cell lung cancer.

Keyphrases

squamous cell
advanced non small cell lung cancer
preterm birth
chemotherapy induced